The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study
PA Kyrle, L Eischer, H Šinkovec… - European Heart …, 2024 - academic.oup.com
Abstract Background and Aims Patients with unprovoked venous thromboembolism (VTE)
have a high recurrence risk, and guidelines suggest extended-phase anticoagulation. Many …
have a high recurrence risk, and guidelines suggest extended-phase anticoagulation. Many …
[HTML][HTML] Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence
Background Deep vein thrombosis (DVT) is a multifactorial disease with several outcomes,
but current classifications solely stratify it based on recurrence risk. Objectives We aimed to …
but current classifications solely stratify it based on recurrence risk. Objectives We aimed to …
Provoked vs minimally provoked vs unprovoked VTE: does it matter?
C Becattini, LA Cimini - Hematology, 2023 - ashpublications.org
Venous thromboembolism (VTE) is a multifactorial disease, and its risk depends on
exposure to risk factors and predisposing conditions. Based on their strength of association …
exposure to risk factors and predisposing conditions. Based on their strength of association …
Age-related differences in the presentation, management, and clinical outcomes of 100,000 patients with venous thromboembolism in the RIETE registry
AG Ortega, D Jiménez, A Pedro-Tudela… - Archivos de …, 2024 - Elsevier
Introduction Although older adults represent a significant proportion of patients with venous
thromboembolism (VTE), the data on the impact of age-related differences in the clinical …
thromboembolism (VTE), the data on the impact of age-related differences in the clinical …
Venous thromboembolism and amyotrophic lateral sclerosis: the Venous Thrombo-Embolism and Sclerosis Lateral Amyotrophic study
A Barnabe, S Genestet, C Gut-Gobert… - Research and Practice …, 2024 - Elsevier
Background Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease.
Given the inflammatory nature of ALS and the high number of ALS-related clinical …
Given the inflammatory nature of ALS and the high number of ALS-related clinical …
Proteomic analysis of human follicular fluid reveals the pharmacological mechanisms of the Chinese patent drug Kunling Pill for improving diminished ovarian reserve
H Wang, D Cao, M Wang, Y Shi, B Wei… - Evidence‐Based …, 2022 - Wiley Online Library
Objective. To explore the pharmacological mechanism of a Chinese patent drug (Kunling
Pill (KLP)) on improving diminished ovarian reserve based on proteomic analysis. Methods …
Pill (KLP)) on improving diminished ovarian reserve based on proteomic analysis. Methods …